Sale of 226 shares at $26.28 per share.
Reporting Person Friedl-Naderer Johanna · Officer Title Chief Commercial Officer · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001915598-26-000004 · filed 2026-08-17 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Dyne Therapeutics, Inc. (DYN)." Disclosed 2026-08-17. https://desqlong.com/cards/0001915598-26-000004-1 (retrieved 2026-09-26).